|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8950 EUR | +5.17% |
|
+0.56% | -41.73% |
| 06-18 | AB Science Secures US Patent for Prostate Cancer Therapy | MT |
| 06-18 | AB Science Secures New U.S. Patent for Masitinib |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Specialty & Advanced Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 78.57M | - | - | - | - | |
| 281B | |||||
| 66.27B | |||||
| 8.24B | |||||
| 8.13B | |||||
| 4.45B |
- Stock Market
- Stocks
- AB Stock
- Charts AB Science
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
